Isolation of uncommon respiratory and enteric Acinetobacter baumannii from hematologic patients and emergence of tigecycline-resistance

Journal of Infection

Volumn 57, Issue 6, 2008, Pages 497-500

  Savini, Vincenzo ^a   Catavitello, Chiara ^a   Pompetti, Franca ^b   Talia, Marzia ^a   Costanzi, Lara ^a   Balbinot, Andrea ^a   Febbo, Fabio ^a   Di Zacomo, Silvia ^b   Esattore, Francesca ^b   D'Antonio, Domenico ^a  

^a SPIRITO SANTO HOSPITAL   (Italy)

^b Department of Hematology ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; DIARRHEA; ENTERITIS; FECES CULTURE; HUMAN; LETTER; LEUKEMIA; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; SPUTUM CULTURE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTERITIS; FECES; HEMATOLOGIC DISEASES; HUMANS; MINOCYCLINE; SPUTUM;

EID: 56949105959     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2008.10.004     Document Type: Letter

References (17)

1. Reid G.E., Grim S.A., Aldeza C.A., Janda W.M., and Clark N.M. Rapid development of Acinetobacter baumannii resistance to tigecycline. Pharmacotherapy 27 8 (2007) 1198-1201
2. Mai M.-H., Tsai H.-C., Lee S.S.-J., Wang Y.-H., Chen Y.-S., Wann S.-R., et al. Multidrug-resistant Acinetobacter baumannii in ventilator associated pneumonia at a medical center in southern Taiwan. J Microbiol Immunol Infect 40 (2007) 401-405
3. Robert E., and Siegel M.D. Emerging Gram-negative antibiotic resistance: daunting challenges, declining sensitivities, and dire consequences. Respir Care 53 4 (2008) 471-479
4. Mezzatesta M.L., Trovato G., Gona F., Nicolosi V.M., Nicolosi D., Caratolli A., et al. In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy. Ann Clin Microbiol Antimicrob 7 (2008) 4
5. Perez F., Hujer A.M., Hujer K., Decker B.K., Rather P.N., and Bonomo R.A. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51 10 (2007) 3471-3484
6. Hu W.S., Yao S.-H., Fung C.-P., Hsieh Y.P., Liu C.P., and Lin J.F. An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii. Antimicrob Agents Chemother 51 11 (2007) 3844-3852
7. Ho Y.-H., Wang L.-S., Chao H.-J., Chang K.C., and Su C.F. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin. J Microbiol Immunol Infect 40 (2007) 537-540
8. Schafer J.J., and Mangino J.E. Multidrug-resistant Acinetobacter baumannii osteomyelitis from Iraq. Emerg Infect Dis 14 3 (2008) 512-514
9. Peleg A.Y., Potoski B.A., Rea R., Adams J., Sethi J., Capitano B., et al. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J Antimicrob Chemother 59 (2007) 128-131
10. Schafer J.J., Goff D.A., Stevenson K.B., and Mangino J.E. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii. Pharmacotherapy 27 7 (2007) 980-987
11. Gallagher J.C., and Rouse H.M. Tigecycline for the treatment of Acinetobacter infections: a case series. Ann Pharmacother 42 9 (2008) 1188-1194
12. Navon-Venezia S., Leavitt A., and Carmeli Y. High Tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 59 (2007) 772-774
13. Kroeger L.A., Laurie B.H., Mitropoulos I.F., Schafer J., and Rotschafer J.C. Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 51 9 (2007) 3431-3433
14. Bassetti M., Repetto E., Righi E., Boni S., Diverio M., Molinari M.P., et al. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections. J Antimicrob Chemother 61 2 (2008) 417-420
15. Pankuch G.A., Lin G., Seifert H., and Appelbaum P.C. Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii. Antimicrob Agents Chemother 52 1 (2008) 333-336
16. Chang P.-Y., Hsueh P.-R., Wu P.-S., Chang P.C., Yang T.T., Lu C.Y., et al. Multidrug-resistant Acinetobacter baumannii isolates in pediatric patients of a university hospital in Taiwan. J Microbiol Immunol Infect 40 (2007) 406-410
17. Anthony K.B., Fishman N.O., Linkin D.R., Gasink L.B., Edelstein P.H., and Lautenbach E. Clinical and microbiological outcomes of serious infections with multidrug-resistant Gram-negative organisms treated with tigecycline. Clin Infect Dis 46 (2008) 567-570